CODHy 2026’s Program
2026 PROGRAM
May 22 Friday 2026
| 08:00-10:00 | Plenary Session 1: Opening Session Chair: Wang Weiqing (China) 08:00-08:10 Chairs Opening Speech Ning Guang (China) 08:10-08:40 Opening Ceremony Opening Report Chairs: Xiao Haipeng (China)；Zhu Dalong (China); A.Enrique Caballero(USA) 08:40-09:00 Energy Metabolism and Gut Microbiota–Wang Weiqing (China) 09:00 -09:20 Longevity and Precision Metabolic Medicine: Itamar Raz(Israel) 09:20 -09:40 AI in Cardiology : Kazem Rahimi (UK) 09:40 -10:00 Comprehensive Diabetes Management Model in the United States: From Guidelines to Clinical Practice–A.Enrique Caballero (USA) |
| 10:00-12:00 | Plenary Session 2: Keynote Session Chairs: Ning Guang (China)；Zhao Jiajun (China); Itamar Raz (Israel) 10:00-10:20 Targeted Therapy for Thyroid Eye Disease: Fan Xianqun (China)—Academician 10:20-10:40 The Role of Dysglycemia in Prediabetes and CVD—Francesco Cosentino (Sweden) 10:40-11:10 Intracellular Protein Degradation-from a Neglected Research Area to the Forefront of Medicine and Drug Development: Aaron Ciechanover (Israel)—-Nobel Laureate 11:10-11:30 Discussion and Photo 11:30-12:00 Hall Turnover and Lunch Box Pickup |
| HALL A | HALL B | HALL C | |
| 12:00-14:00 | Lunch Symposium A | Lunch Symposium B | Lunch Symposium C |
| 14:00-16:00 | Session 1| Endocrine Tumors Chairs: Guo Lixin (China) Chen Gang (China) Li Yanbing (China) Zhang Junqing (China) Massimo Terzolo (Italy) 14:00-14:20 Adrenal Tumors 2026 State the Art –Massimo Terzolo (Italy) 14:20-14:40 Tumor Neoantigens and Endocrine Tumor –Ye Lei (China) 14:40-15:00 Wha t is new on management of localized adrenocortical carcinoma –Massimo Terzolo (Italy) 15:00-15:20 Pathological Diagnosis of Parathyroid Lesions–-Xie Jing (China) 15:20-15:40 Management of ACC in Ruijin Hospital–Wang Weiqing (China) 15:40-16:00 Q&A and Panel Discussion | Session 2| Diabetes Management: News at the Horizon Chairs: Yang Tao (China) Wang Guang (China) Paolo Fiorina (Italy) Luc Van Gaal (Belgium) 14:00-14:20 Overview of International Guidelines for Lipids Management in Diabetes–Luc Van Gaal (Belgium) 14:20-14:40APOC-3 Targeted Lipid-Lowering Drug: New Breakthrough —Lu Jieli (China) 14:40-15:00 New Insulin in Diabetes– Paolo Fiorina (Italy) 15:00-15:20 A feeding-Induced Myokine Modulates Glucose Homeostasis—Song Yongfeng (China) 15:20-15:40 ChinaMAP: Discovery of Therapeutic Targets and Novel Mechanisms for Type 2 Diabetes-Cao Yanan (China) 15:40-16:00 Q&A and Panel Discussion | Session 3| Young Scientist Forum Chairs: Peng Yongde (China) Gao Hongwei (China) Zhang Yuwei (China) Aaron Ciechanover (Israel) Itamar Raz (Israel) Clinical Evidence of 5:2 Diet and Exercise Interventions in Type 2 Diabetes: Efficacy and Phenotypic Heterogeneity Li Mian (China) 15min Personalized Cardiovascular Diseases Risk Prediction and Its Application Liu Fangchao (China) 15min Fasting-induced miR-7a-5p in AgRP Neurons Regulates Food Intake Lv Qianqian (China) 15min An Inter-organ Neural Circuit for Appetite Suppression Zhang Tong (China) 15min Genes, Microbiome, and Aging: Towards an Etiological Understanding of Metabolic Multimorbidity Wang Tiange (China) 15min How Stressed-out Brain Influence on Gut Immunity Chang Hao (China) 15min Q&A and Panel Discussion 30min |
| 16:00-18:00 | Session 4| Technologies and Treatments Chairs: Xia Weibo (China) Wang Guixia (China) Li Ling (China) Itamar Raz (Israel) Edith Wing Kar Chow (HK SAR) Bexagliflozin Starts a New hapter of SGLT2i in Diabetes Management Wang Weiqing (China) 20min What Should be the Best Therapeutic Choice for the Early Treatment of Type 2 Diabetes? Itamar Raz (Israel) 20min Hypertension in Young-onset Diabetes Edith Wing Kar Chow (HK SAR) 20min Non-invasive Spectroscopic Technology Enable Digital Medicine Chen Chang (China) 20min Study on Linafexor Improving Obesity and Fatty Liver Disease Linafexor Zhang Yifei (China) 20min Q&A and Panel Discussion 20min | Session 5| Guidelines for the Management of Hyperglycemia in Type 2 Diabetes Chairs: Mu Yiming (China) Yuan Huijuan (China) A.Enrique Caballero (USA) Francesco Cosentino (Sweden) ADA/AHA/ACC Diabetes with Hypertension Management: Latest Guideline Interpretation and Clinical Practice A.Enrique Caballero (USA) 20min Current and Future Guideline Recommendations for the Management of Hypertension in Diabetes in Asia Wang Jiguang (China) 20min lDF Global Recommendations for the management of Type 2 Diabetes Andrew Boulton (UK) 20min ESC Guidelines for the Management of CVD in Diabetes Francesco Cosentino (Sweden) 20min Q&A and Panel Discussion 40min | Session 6| Cardio-Renal Disease in Diabetes Chairs: Xiang Guangda (China) Bi Yan (China) Chen Hong (China) Michal Laufer-Perl (Israel) Kazem Rahimi (UK) Prediction and Prevention of the CVD in of Type 1 Diabetes Alicia Jenkins (Australia) 20min CKD in Type 1 Diabetes Paolo Fiorina (Italy) 20min The Link Between Heart Failure and Kidney Disease: How to Face in Diabetes? Michal Laufer-Perl (Israel) 20min Precision Subtyping of Diabetes Participants for Intensive Blood Pressure Management Xu Yu (China) 20min Hypertension and Cardio Renal Disease in Diabetes Kazem Rahimi (UK) 20min Q&A and Panel Discussion 40 min |
May 23 SATURDAY 2026
| HALL A | HALL B | HALL C | |
| 08:30-10:10 | Session 7| From Infrastructure to Digital Intelligence Chairs: Qin Guijun (China) Xu Jixiong (China) Alicia Jenkins (Australia) Jaron Rabinovici (Israel) The Physical and Ethical Roadblocks on our Journey toPersonal-tailored Medicine Aaron Ciechanover (Israel) 15min Digital Practices of Lifecycle Health Management Xu Yuchen (China)15min From Data to Decisions: The Role of AI in Managing Obesity and Diabete Alicia Jenkins (Australia) 15min The Role of AI in Gynecology Obesity Jaron Rabinovici (Israel) 15min Integrating HPC and AI to Advance Protein-Ligand Binding Interaction Prediction Huang Niu (China) 15min Intelligent Methodology Development for Molecular Multimodal Big Data Analysis Shen Hongbin (China) 15min Q&A and Panel Discussion 25min | Session 8| New Perspective in Obesity and Diabetes Chairs: Guan Qingbo (China) Fu Songbo (China) Edith Wing Kar Chow (HK SAR) Michal Laufer-Perl (Israel) About MMC: An Innovative Model for Chronic Disease Management Wang Weiqing（China）20min Safety of Long Term Treatment with GLP-1 Edith Wing Kar Chow (HK SAR) 20min Glucose Homeostasis: A New Perspective on Improving Cognitive Impairment and Frailty Shi Yongquan (China) 20min The Effect of GLP-1ra on CVD Michal Laufer-Perl (Israel) 20min Q&A and Panel Discussion 20min | Session 9| Obesity Management Chairs: Zhang Huijie (China) Liu Libin (China) Bi Yan (China) Luc Van Gaal (Belgium) Paolo Fiorina (Italy) Enhance Weight Management through Primary Care in China Xu Yu (China) 20min Treatment in Obesity with T1 Diabetes Paolo Fiorina (Italy) 20min From Visceral Fat to Ectopic Fat Luc Van Gaal (Belgium) 20min Microbiota-Derived Mechanisms and Precision Interventions in Obesity Liu Ruixin (China) 20min Q&A and Panel Discussion 20min |
| 10:10-11:50 | Session 10| Thyroid and Bone Metabolism Chairs: Xia Weibo (China） Jiao Kai (China) Qiao Hong (China) Jaron Rabinovici (Israel) Advancing the Understanding and Practice of Diabetes Osteoporosis Liu Jianmin（China) 20min Advances in Postoperative Management of Thyroid Cancer from an Endocrine Perspective, 2026 Wang Yufan (China) 20min From Bone to Ovary: Rethinking Hyperparathyroidism in Women’s Health, ovarian function and pregnancy outcome Jaron Rabinovici (Israel) 20min A novel oculometry system for Comprehensive Thyroid Eye Disease Assessment: Accuracy, Reproducibility, and Prognostic Utillity Shen Liyun (China) 20min Q&A and Panel Discussion 20min | Session 11| Face-to-Face with Journal Editors-in-Chief Chairs: Xiao Haipeng (China) Mu Yiming（China) Andrew Boulton (UK) Kazem Rahimi (UK) Tips for Publications in the GenAI Era Wang Hui (China) 20min From Big Data to Clinical Impact: Publishing Cardiometabolic Research That Changes Practice Kazem Rahimi (UK) 20min From Manuscript to Impact: An Editor-in-Chief’s Perspective on Publishing High-Quality Diabetes Research Andrew Boulton (UK) 20min Q&A and Panel Discussion 20min Moderator: Liu Jianmin (China) | Session 12| Early Management of CKM Chairs: Wang Weiqing (China) Qin Guijun (China) Kuang Hongyu (China) Peng Yongde (China) Holistic Management Strategy for CKM Li Ling (China) 20min Comprehensive Benefits of CKM: Insights from Renal Outcome Trials Chen Hong (China) 20min GLP-1RA in Early Glycemic Management Shi Yongquan (China) 20min Interpretation of Real-World Research Data & Application Insights of GLP-1RA Ma Jing (China) 20min Q&A and Panel Discussion 20min |
11:50-12:00 12:00-14:00 | Lunch box Pickup Lunch Symposium D | Lunch box Pickup Lunch Symposium E | Lunch box Pickup Lunch Symposium F |
| 14:00-16:00 | Session 13| Longevity with Obesity and Diabetes Chairs: Kuang Hongyu (China) Gao Hongwei (China) Yan Zhaoli (China) Hongjie Li (USA) Jaron Rabinovici (Israel) Decoding the Pharmaceutical Code of the Cholesterol-Lowering siRNA Drug Inclisiran Bian Xiaolan (China) 20min From Fetus to Menopause Obesity and Health Jaron Rabinovici (Isreal) 20min Whole-Organism Single-Cell Insights for Precision Longevity Interventions Hongjie Li (USA) 20min Metabolic Heterogeneity Linking Obesity, Diabetes, and Longevity: Insights from the 4C Study Lu Jieli (China) 20min Genetic Decoding of Complex Traits: from Genetic Origins to Cellular Roots Yang Jian (China) 20min Q&A and Panel Discussion 20min | 13:00-16:00 Session 14| Diabetic Foot Chairs: Ning Guang (China) Xue Yaoming (China) Qu Shen (China) Andrew Boulton (UK) David G. Armstrong (USA) Mitochondrial Metabolism and Vascular Diseases Sun Aijun (China) 20min The Diabetic Foot: The Current Situation in China Tang Zhengyi (China) 20min How Far Have We Come in 40 Years of Diabetic Foot Research? Diagnosis, Screening and Evidence-Based Treatments Andrew Boulton (UK) 30min Mind the Foot: Psychology of Foot Ulceration and Healing Loretta Vileikyte (UK) 20min Podiatric Surgery and Limb Salvage David G. Armstrong (USA) 20min Directed Atherectomy Guided by Intravascular Real-Time Imaging: A Novel Technique for Improving Lower Extremity Arterial Perfusion in Diabetic Foot Patients Feng Jiaxuan (China) 20min Q&A Discussion and Case Presentation(s). 20min | Session 15| MMC Session(I） Opening Ning Guang, China MMC Introduction Wang Weiqing, China 30min Chrocare AI Latest Innovations Zhang Yifei, China Cao Yanan, China Highlights of Latest MMC Research Publications Dai Yuancheng, China Fu Songbo,China Li li,China Wan Qin,China Zhao Dong,China Roundtable Discussion Topic I: Discussion on MMC Weight Management Moderator:Zhang Yifei, China Panelist： Ma Jing,China； Niu Yu,China； Sun Xia,China； Xu Jixiong,China； Zhou Huimin,China Topic II: Discussion on MMC Whole-district Model Moderator: TBC Panelist： Chen Lei,China Li Zuohong,China Lv Shuangyan,China Wang Yan,China Zhou Jie,China Impact of MMC on Departmental Development Under the DRG Payment System Chen Genben,China Roundtable Discussion The Impact of MMC on Academic Discipline Building Moderator:Hu Ling, China Panelist: Dong Yin,China Wu Xiaohong,China Zheng Qidong,China MMC Opening Ceremony Summary and Group Photo |
| 16:00-18:00 | / | / | Session 16| MMC Session(II） |